Medicine and Dentistry
Radiation Therapy
100%
Immunotherapy
81%
Neoplasm
77%
Malignant Neoplasm
48%
Lung Cancer
45%
Non Small Cell Lung Cancer
31%
microRNA
31%
Low Drug Dose
23%
Metastatic Carcinoma
18%
Abscopal Effect
18%
Acute Lymphoblastic Leukemia
17%
T Cell
17%
Cancer Cell
16%
Primary Tumor
16%
Cytotoxic T-Cell
15%
Immune Response
15%
Disease
13%
Drug Megadose
13%
Biological Marker
12%
Programmed Cell Death
12%
Immunocompetent Cell
12%
Lung Tumor
12%
Lymphocytopenia
12%
Carcinogenesis
11%
Tumor Microenvironment
11%
Phase II Trials
11%
Nanoparticle
11%
Immunological Memory
11%
Tumor Suppressor Protein
11%
Indoleamine 2,3 Dioxygenase
11%
Scatter Factor
11%
Dosimetry
11%
Tumor Immunology
11%
Myeloid-Derived Suppressor Cell
11%
Lymphocyte
11%
Stereotactic Body Radiation Therapy
10%
In Vitro
10%
Cancer Treatment
9%
Tumor Progression
8%
Stroma
8%
Tumor Antigen
8%
Radiosensitivity
8%
Systemic Disease
8%
Glioblastoma
7%
Tumor Model
7%
Cell Line
7%
Oncology
7%
Specific Tumor
7%
Tumor Regression
7%
Immunosuppressive Treatment
7%
Keyphrases
MicroRNA
37%
In Cancer
36%
Tumor
31%
Radiation Therapy
30%
Low-dose Radiation
29%
C-Met
28%
Radiotherapy
26%
Abscopal Response
20%
Tumor Immunology
19%
Non-small Cell Lung Cancer (NSCLC)
18%
Combination Immunotherapy
17%
Tumor Immunotherapy
17%
Immune Response
17%
Tumor Microenvironment
16%
Anti-PD-1
16%
Immune Cells
15%
Programmed Death-ligand 1 (PD-L1)
14%
Checkpoint Inhibitors
13%
T Cells
13%
Lymphopenia
13%
Tumor Cells
12%
Cancer Cells
12%
Metastatic Disease
12%
Phase II Trial
12%
Combined Radiotherapy
11%
Survival Outcomes
11%
Tumor Stroma
11%
Secondary Tumor
11%
Transcribed Ultraconserved Region
11%
Stereotactic Body Radiation Therapy
11%
Immunoradiotherapy
11%
Resistance to Immunotherapy
11%
Lung Tumor
11%
Bone Morphogenetic protein-7 (BMP-7)
11%
Absolute Lymphocyte Count
11%
Hepatocyte Growth Factor
11%
Radiotherapy Techniques
11%
Childhood Acute Lymphoblastic Leukemia
11%
Dosimetry
11%
Lung Cancer Patients
11%
MicroRNA-34a (miR-34a)
11%
Lipid Metabolism
11%
Apologizing
11%
Overexpression
10%
Lung Cancer
10%
Abscopal Effect
10%
Tumor Antigen
9%
PD-1 Resistance
9%
Cancer Immunotherapy
9%
Quantitative PCR
9%
Immunology and Microbiology
Immunotherapy
86%
Immune Response
42%
Mouse
37%
Immunocompetent Cell
36%
Low Drug Dose
33%
T Cell
26%
Cancer Cell
24%
Drug Megadose
24%
Stroma
19%
Tumor Cell
18%
Untranslated Region
16%
Immunological Memory
15%
Gene Expression
14%
CD8
14%
Programmed Death-Ligand 1
14%
Cytotoxic T-Cell
13%
Regulatory T Cell
13%
Immunosuppression
13%
Agonist
12%
Tumor Immunology
12%
Cell Line
11%
Adaptive Immune System
11%
Indoleamine 2,3-dioxygenase
11%
Myeloid-Derived Suppressor Cell
11%
Lymphocyte Count
11%
Cell Proliferation
11%
Methanol Extraction Residue
11%
T-Helper Cell
10%
Mouse Model
10%
Blood Plasma
9%
Immune Evasion
9%
Tumor Volume
9%
Immune System
9%
Lymphocytopenia
9%
CD4
8%
P53
8%
Tumor Immunity
8%
Tumor Escape
8%
Epithelial Mesenchymal Transition
7%
Cancer Immunotherapy
7%
Cell Population
7%
Oxidative Phosphorylation
7%
Immunosuppressive Drug
7%
Cell Function
7%
Leg
7%
RNA Sequence
6%
Cell Growth
6%
Cytotoxic T Cell
6%
Oxidative Stress
6%
Tumor-Associated Macrophage
6%
